Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 2/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 2/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | F2R | P25116 | 3/20 | 0.39 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6229688 | 0.98 | TNKS2 (0.44) | TNKS2HPGDGNAI3GNAO1GNAI1 | |
| SCHEMBL485662 | 0.89 | FAAH (0.44) | GNAI3GNAO1GNAI1ITGB3ITGA2B | |
| SCHEMBL8391885 | 0.86 | — | — | |
| SCHEMBL8392196 | 0.82 | HPGD (0.55) | HPGDGAALMNATSHR | |
| SCHEMBL6392074 | 0.82 | HPGD (0.60) | HPGDGAATSHR | |
| SCHEMBL8393928 | 0.80 | HPGD (0.63) | HPGDGAAALOX15TSHR | |
| SCHEMBL5245833 | 0.80 | HPGD (0.63) | HPGDGAAALOX15TSHR | |
| SCHEMBL8018459 | 0.80 | EPHX1 (0.53) | HPGDGNAI3GNAO1GNAI1ALOX15 | |
| SCHEMBL11317564 | 0.79 | GNAI3 (0.43) | TNKS2GNAI3GNAO1GNAI1ITGB3 | |
| SCHEMBL14723948 | 0.78 | ITGB3 (0.49) | TNKS2GNAI3GNAO1GNAI1ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250325542-A1 | INHIBITORS OF ANTIMOCROBIAL RESISTANCE AND METHOS USING SAME | BAYLOR COLLEGE MEDICINE (US) | 2025-10-23 | — | — | US | disclosed |
| CN-104987326-A | Mass labels for biomolecules containing a 2,6-dimethyl-piperidin-L-YL methylene or a pyrimidin-2-YL thiomethylene mass marker moiety and a succinimid-oxy-carbonyl reactive functional group | ELECTROPHORETICS LTD | 2015-10-21 | — | — | CN | disclosed |
| EP-1517894-A1 | N-BENZYL-3-PHENYL-3-HETEROCYCLYL-PROPIONAMIDE COMPOUNDS AS TACHYKININ ANTAGONISTS AND/OR SEROTONIN REUPTAKE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2005-03-30 | — | — | EP | disclosed |
| WO-1995018619-A9 | BICYCLIC FIBRINOGEN ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2004-10-21 | — | — | WO | disclosed |
| WO-2004005255-A1 | N-BENZYL-3-PHENYL-3-HETEROCYCLYL-PROPIONAMIDE COMPOUNDS AS TACHYKININ AND/ OR SEROTONIN REUPTAKE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2004-01-15 | — | — | WO | disclosed |
| CN-1117569-C | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORP (US) | 2003-08-13 | — | — | CN | disclosed |
| CN-1143323-A | Bicyclic fibrinogen antagonists | SMITHKLINE BEECHAM CORP (US) | 1997-02-19 | — | — | CN | disclosed |
| US-4289772-A | PHOSPHODIESTERASE INHIBITORS | PFIZER INC. (US) | 1981-09-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250325542-A1 | INHIBITORS OF ANTIMOCROBIAL RESISTANCE AND METHOS USING SAME | BPGM, PNMT, DDT | TNKS2 3393/4885HPGD 2760/4885GNAI3 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.